FDA Tells Viracor-IBT to Stop Selling Two Zika Tests – 360Dx

0
97



FDA Tells Viracor-IBT to Stop Selling Two Zika Tests
360Dx
Earlier this month, the FDA sent a letter to Viracor-IBT telling it to stop marketing the Zika Virus IgG test for the qualitative detection of Zika IgG antibodies in serum or plasma, and the Zika Virus IgG and IgM Panel. The agency provided emergency
Zika Virus Testing Market Scenario, Opportunities, Trends and growth prospective 2022satPRnews (press release)

all 2 news articles »



Source link

NO COMMENTS

LEAVE A REPLY